Patent Assignment
Reel/Frame 015885/0924
Assignment of Assignor's Interest
Recorded: 2004-10-15
Pages: 4
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
Application:
10/652,791 →
Publication:
US 2005/0106726